Cargando…
Histone methyltransferase Smyd3 is a new regulator for vascular senescence
Endothelial cell senescence is one of the main risk factors contributing to vascular diseases. As increasing number of “epigenetic drugs” entering clinical trials, understanding the mechanism of epigenetic regulation in vascular aging has significant implications in finding targets to cure vascular...
Autores principales: | Yang, Di, Wei, Gang, Long, Fen, Nie, Hongbo, Tian, Xiaoli, Qu, Lefeng, Wang, ShuangXi, Li, Peng, Qiu, Yue, Wang, Yang, Hong, Wanjin, Ni, Ting, Liu, Xinhua, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511874/ https://www.ncbi.nlm.nih.gov/pubmed/32779886 http://dx.doi.org/10.1111/acel.13212 |
Ejemplares similares
-
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity
por: Su, Zhenghua, et al.
Publicado: (2022) -
Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022) -
Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019) -
Smyd3-PARP16 axis accelerates unfolded protein response and vascular aging
por: Yang, Di, et al.
Publicado: (2020) -
Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
por: Foreman, Kenneth W., et al.
Publicado: (2011)